Yet, when delivered into the host, OVA conjugated to anti‐DCIR‐1 and anti‐DEC205, expressed by CD8− and CD8+ DCs respectively, suppressed OVA‐expressing B16 tumor to a similar extent (Neubert et al, 2014). The gene discussed is CD8A; the disease is neoplasm.